Compare MSGY & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSGY | PRPH |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.0M | 21.9M |
| IPO Year | 2025 | 1997 |
| Metric | MSGY | PRPH |
|---|---|---|
| Price | $2.83 | $0.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 3.2M |
| Earning Date | 12-12-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $23,318,482.00 | $5,055,000.00 |
| Revenue This Year | N/A | $221.82 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $27.08 | ★ N/A |
| Revenue Growth | ★ 13.04 | N/A |
| 52 Week Low | $0.83 | $0.12 |
| 52 Week High | $22.20 | $0.93 |
| Indicator | MSGY | PRPH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 24.58 |
| Support Level | N/A | $0.12 |
| Resistance Level | N/A | $0.22 |
| Average True Range (ATR) | 0.00 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 4.23 |
Masonglory Ltd is a a holding company and operates through subsidiary. It is engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong. As a subcontractor, It provide customers with comprehensive wet trades works solutions, which principally include plastering on floors, ceilings and walls, tile laying on internal and external walls and floors, brick laying, floor screeding, and marble works.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.